about
A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLDBeneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis.Effects of four Bifidobacteria on obesity in high-fat diet induced rats.Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.Gut microbiota and Ma-Pi 2 macrobiotic diet in the treatment of type 2 diabetes.Influence of diet on gut microbiota, inflammation and type 2 diabetes mellitus. First experience with macrobiotic Ma-Pi 2 diet.Probiotics as a novel treatment for non-alcoholic Fatty liver disease; a systematic review on the current evidencesProbiotics and liver diseaseClinical approaches to non-alcoholic fatty liver diseaseImpact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials.Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease.Pharmacological agents for nonalcoholic steatohepatitis.Emerging and future therapies for nonalcoholic steatohepatitis in adults.Probiotic as a novel treatment strategy against liver diseaseGut-Liver Axis Derangement in Non-Alcoholic Fatty Liver DiseaseMore on current evidences on probiotics as a novel treatment for non-alcoholic Fatty liver disease.Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis.Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy.Editorial: probiotics in NASH - more studies are needed; authors' reply.Treatment options for nonalcoholic fatty liver disease.
P2860
Q26752487-3BF8ECF6-18C9-4EF3-AD6E-48B4D1634D23Q30377409-C5AB3552-3CEB-49E6-B19D-C73B741E4568Q33998629-DF3785F8-3B47-47D1-A27C-607833D4C47BQ34153569-D00103C6-06CA-4AB8-BC49-2EDDF4B7E76BQ34499017-C9688001-9081-4934-A4DA-7685C7817BCFQ34669445-56C47E8A-65FC-4C95-A045-CBF267B241B6Q35095134-DDE691EA-A312-47F8-AC2F-80E151EB84FFQ37034650-8847C7BB-F26C-405A-A08B-CCD9E4B82D1CQ37372411-765289AD-5409-4C90-AC2E-9956403662CDQ37596187-4408D595-48EC-4A7E-BD5B-B9EE794F410BQ37978785-1607576F-F085-4F5A-92F5-2A2B1EE62CCEQ38408904-1FDDBBB9-816D-4B22-8E38-6D64E1AEC403Q38552387-C9ABF9D3-3BC9-4921-95CA-69CA0C7BD947Q38827586-8ED1D451-C543-4E75-AB82-A1A9E220FF0FQ39974040-5C627AC2-CDEC-4464-B4F5-23D2C943424AQ41552497-6374566A-5FBB-4E7E-81E8-FE6FD25F6775Q42083796-938EA0A8-ED45-4230-85C4-6BB96A82C585Q42367659-D6B353EA-75D2-471C-9030-D2DBBF9212E7Q43217282-0A0A87DE-9021-4050-9328-4B16578B3068Q47116789-B7C4D351-1E94-415D-A2C4-3040A12F30DBQ50804062-FC029E60-2318-4B41-96EA-0B51005709A1Q55460608-BB11C0E4-7143-4309-AFF1-324593ECAD92
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The effect of a probiotic on hepatic steatosis
@en
The effect of a probiotic on hepatic steatosis
@nl
type
label
The effect of a probiotic on hepatic steatosis
@en
The effect of a probiotic on hepatic steatosis
@nl
prefLabel
The effect of a probiotic on hepatic steatosis
@en
The effect of a probiotic on hepatic steatosis
@nl
P2093
P2860
P1476
The effect of a probiotic on hepatic steatosis
@en
P2093
Alena Horska
Anna Mae Diehl
Gillian Buckley
Jeanne M Clark
Steven F Solga
P2860
P304
P356
10.1097/MCG.0B013E31816D920C
P577
2008-11-01T00:00:00Z